4/18
08:03 pm
tngx
Is Tango Therapeutics (TNGX) Building the Right Leadership Mix to Navigate Complex Oncology Pipelines? [Yahoo! Finance]
Low
Report
Is Tango Therapeutics (TNGX) Building the Right Leadership Mix to Navigate Complex Oncology Pipelines? [Yahoo! Finance]
4/15
09:05 am
tngx
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
Medium
Report
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
4/10
12:06 pm
tngx
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by B. Riley Financial, Inc..
Neutral
Report
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by B. Riley Financial, Inc..
4/6
05:38 pm
tngx
Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) [Yahoo! Finance]
Low
Report
Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) [Yahoo! Finance]
4/2
09:00 am
tngx
Tango Therapeutics (TNGX) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
Medium
Report
Tango Therapeutics (TNGX) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
3/30
01:58 pm
tngx
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge [Yahoo! Finance]
Low
Report
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge [Yahoo! Finance]
3/29
08:34 am
tngx
Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum [Yahoo! Finance]
Medium
Report
Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum [Yahoo! Finance]
3/21
01:31 am
tngx
Low
Report
3/13
03:04 pm
tngx
Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings [Yahoo! Finance]
Low
Report
Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings [Yahoo! Finance]
3/11
04:35 pm
tngx
Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX) [Yahoo! Finance]
Low
Report
Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX) [Yahoo! Finance]
3/11
09:44 am
tngx
Tango Therapeutics (TNGX) had its price target raised by Mizuho from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Medium
Report
Tango Therapeutics (TNGX) had its price target raised by Mizuho from $19.00 to $20.00. They now have an "outperform" rating on the stock.
3/9
09:03 am
tngx
Tango Therapeutics (TNGX) had its price target raised by Stifel Nicolaus from $15.00 to $24.00. They now have a "buy" rating on the stock.
Low
Report
Tango Therapeutics (TNGX) had its price target raised by Stifel Nicolaus from $15.00 to $24.00. They now have a "buy" rating on the stock.
3/9
04:04 am
tngx
Tango Therapeutics (TNGX) Soars 52% on Buy Reco [Yahoo! Finance]
Medium
Report
Tango Therapeutics (TNGX) Soars 52% on Buy Reco [Yahoo! Finance]
3/8
07:44 am
tngx
Tango Therapeutics (TNGX) Valuation Check After Strong Share Price Momentum And High P/S Multiple [Yahoo! Finance]
Medium
Report
Tango Therapeutics (TNGX) Valuation Check After Strong Share Price Momentum And High P/S Multiple [Yahoo! Finance]
3/7
02:59 am
tngx
Medium
Report
3/6
10:00 pm
tngx
Tango Therapeutics, Up 39% This Year, Surges Again On Another Cancer Pact [Yahoo! Finance]
Medium
Report
Tango Therapeutics, Up 39% This Year, Surges Again On Another Cancer Pact [Yahoo! Finance]
3/6
05:33 pm
tngx
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/6
04:08 pm
tngx
Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise [Seeking Alpha]
Low
Report
Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise [Seeking Alpha]
3/6
08:55 am
tngx
Tango Therapeutics (TNGX) had its price target raised by Wedbush from $15.00 to $19.00. They now have an "outperform" rating on the stock.
Low
Report
Tango Therapeutics (TNGX) had its price target raised by Wedbush from $15.00 to $19.00. They now have an "outperform" rating on the stock.
3/6
08:29 am
tngx
Tango Therapeutics (TNGX) had its price target raised by Guggenheim from $18.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
Tango Therapeutics (TNGX) had its price target raised by Guggenheim from $18.00 to $20.00. They now have a "buy" rating on the stock.
3/6
08:03 am
tngx
Tango Therapeutics (TNGX) had its price target raised by HC Wainwright from $13.00 to $27.00. They now have a "buy" rating on the stock.
Low
Report
Tango Therapeutics (TNGX) had its price target raised by HC Wainwright from $13.00 to $27.00. They now have a "buy" rating on the stock.
3/5
08:30 pm
tngx
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
Low
Report
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
3/5
08:07 pm
tngx
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/5
07:29 am
tngx
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]
High
Report
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]
3/5
07:00 am
tngx
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
High
Report
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights